Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience-Reference-Cited by-同舟云学术

Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience

Published:2021-02 Issue:2 Volume:21 Page:e112-e119
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kaloyannidis Panayotis^ORCID,Omari Rawan,Eldebawy Eman,Al Shaibani Eshrak,Apostolidis John,Hindi Taghreed,Raslan Heba,Al Garni Ayed,Al Buali Ahmed,Al Anezi Khalid,Al Hashmi Hani

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference45 articles.

1. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry;Mounier;Biol Blood Marrow Transplant,2012

2. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsedhemosensitive Hodgkin’s disease: a randomised trial;Schmitz;Lancet,2002

3. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomised trial;Linch;Lancet,1993

4. Outcomes of Hodgkin’s lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation;Kaloyannidis;Biol Blood Marrow Transplant,2012

5. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma;Bröckelmann;Ann Oncol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience;Clinical Lymphoma Myeloma and Leukemia;2021-09